Skip to content

Study · Systematic review · 2023

1 result

Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review.

Masson R, Shih T, Jeong C, Shi VY, Hsiao JL

Journal of drugs in dermatology : JDD1 Aug 2023Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanSystematic reviewEfficacy outcome

    In a systematic review of hormonal treatments for hidradenitis suppurativa, case reports of patients treated with liraglutide noted improvement in the disease.

    In plain wordsIn a review of hormone treatments for hidradenitis suppurativa, case reports noted improvement in patients treated with liraglutide.

    Outcome
    Direction not reportedImprovement in hidradenitis suppurativa
    Study

    n: not reported in source

    Outcome group
    Skin and hair · Skin and wound
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Improvement in HS was also noted in case reports of patients treated with buserelin acetate, leuprolide, flutamide, and liraglutide
    1 context sentence
    Summary · context
    Metabolic treatments reported include metformin (n=8) and liraglutide (n=2).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 11:11 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:05 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.